Bio-Rad Laboratories, Inc.  

(Public, NYSE:BIO)   Watch this stock  
Find more results for BIO
117.76
-0.50 (-0.42%)
Jul 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 117.39 - 118.36
52 week 113.02 - 134.13
Open 117.88
Vol / Avg. 0.00/79,660.00
Mkt cap 3.39B
P/E 53.53
Div/yield     -
EPS 2.20
Shares 23.73M
Beta 1.19
Inst. own 77%
Aug 5, 2014
Q2 2014 Bio-Rad Laboratories Inc Earnings Call - 5:00PM EDT - Add to calendar
Aug 5, 2014
Q2 2014 Bio-Rad Laboratories, Inc. Earnings Release - 4:00PM EDT - Add to calendar
Jun 2, 2014
Bio-Rad Laboratories, Inc. at Jefferies Global Healthcare Conference
May 6, 2014
Q1 2014 Bio-Rad Laboratories, Inc. Earnings Conference Call
May 6, 2014
Q1 2014 Bio-Rad Laboratories, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 1.31% 3.65%
Operating margin 4.02% 7.93%
EBITD margin - 14.85%
Return on average assets 0.78% 2.28%
Return on average equity 1.21% 3.70%
Employees 7,750 -
CDP Score - -

Address

1000 ALFRED NOBEL DR
HERCULES, CA 94547
United States - Map
+1-510-7247000 (Phone)
+1-510-7415815 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bio-Rad Laboratories, Inc. (Bio-Rad), manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics.. As of December 31, 2011, the Company had direct distribution channels in over 35 countries outside the United States through subsidiaries. In January 2013, the Company purchased AbD Serotec, a division of MorphoSys AG. In April 2014, Bio-Rad Laboratories Inc purchased GnuBIO, Inc.

Officers and directors

Norman D. Schwartz Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Christine A. Tsingos Chief Financial Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Shawn M. Soderberg Executive Vice President, General Counsel, Secretary
Age: 53
Bio & Compensation  - Reuters
Bradford J. Crutchfield Executive Vice President, President, Life Science Group
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John Goetz Executive Vice President, President, Clinical Diagnostics Group
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Giovanni Magni Executive Vice President, International Sales Manager
Age: 57
Bio & Compensation  - Reuters
Ronald W. Hutton Vice President, Treasurer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alice N. Schwartz Director
Age: 87
Bio & Compensation  - Reuters
Louis C. Drapeau CPA Independent Director
Age: 70
Bio & Compensation  - Reuters
Robert M. Malchione Independent Director
Age: 56
Bio & Compensation  - Reuters